Results of the tibioperoneal trunk repair in patients with advanced atherosclerosis
https://doi.org/10.35401/2541-9897-2023-26-2-13-20
Abstract
Objective: To study immediate and long-term results of the tibioperoneal trunk repair (plastic reconstruction or prosthetic repair) during femoropopliteal bypass.
Materials and methods: In our retrospective cohort study we analyzed surgical treatment results of 109 patients with lower extremities atherosclerosis who were treated in the Vascular Surgery Unit of Interregional Clinical Diagnostic Center (Kazan, Russian Federation) from 2018 to 2020. 26 (23.8%) patients were hospitalized for stage IB-IIA acute arterial insufficiency with atherothrombosis, and 83 (76.1%) patients were admitted with critical limb ischemia (CLI) as a result of advanced atherosclerosis. Among the CLI patients, 43 (39.4%) of them had stage III chronic arterial insufficiency, and 40 (36.7%) patients had stage IV chronic arterial insufficiency.
The study selection criteria included extensive femoral and popliteal arteries disease and significant stenosis or occlusion of the tibioperoneal trunk. TASC II type C lesions were detected in 2 (1.8%) patients, while 107 (98.2%) patients were diagnosed with TASC II type D lesions. Based on the GLASS classification, all 109 (100%) patients had FP grade 3-4 femoropopliteal lesions with concomitant IP grade 1-4 tibial lesion. The main group included 24 (22%) patients who underwent femoropopliteal bypass with plastic or prosthetic repair of the tibioperoneal trunk using an original technique. The control group included 85 (78%) patients who underwent bypass surgery without the tibioperoneal trunk repair. Isolated femorotibial bypass was performed in 7 (8.2%) patients, and 78 (91.7%) patients underwent femoropopliteal bypass with a reversed autogenous vein.
Results: We followed up patients for 2 years after surgery. Immediate technical success was 97.24% (106/109). Graft thrombosis was reported in 3 cases. No difference between the groups was observed. Long-term graft patency was significantly higher in the main group (P = .044) and significantly associated with age (RR = 0.96; 95% CI of 0.92 to 1.00, P = .03), type 2 diabetes mellitus (RR = 2.10; 95% CI of 1.10 to 4.10, P = .03), and history of the tibioperoneal trunk repair (RR = 0.43; 95% CI of 0.18 to 1.00, P = .06). Variables associated with patency in the univariate regression at a significance level P ≤ .1 were included in a multivariate model that demonstrated the combined effect of predictors on the outcome.
Conclusions: Femoropopliteal bypass with the tibioperoneal trunk repair improves treatment results in patients with extensive peripheral artery disease and immediately threatened limbs or a threat to a limb within 2 years.
About the Authors
N. V. KrepkogorskiyRussian Federation
Nikolay V. Krepkogorskiy, Cand. Sci. (Med.), Cardiovascular Surgeon; Assistant, Department of Cardiovascular and Endovascular Surgery
ulitsa Karbysheva 12A, block A, Kazan, 420087, Republic of Tatarstan, Russian Federation
R. A. Bredikhin
Russian Federation
Roman A. Bredikhin, Dr. Sci. (Med.), Cardiovascular Surgeon, Department Head; Associate Professor, Department of Cardiovascular and Endovascular Surgery
Kazan
References
1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45 Suppl S:S5–67. PMID: 17223489. https://doi.org/10.1016/j.jvs.2006.12.037
2. Conte MS, Bradbury AW, Kolh P, et al; GVG Writing Group for the Joint Guidelines of the Society for Vascular Surgery (SVS), European Society for Vascular Surgery (ESVS), and World Federation of Vascular Societies (WFVS). Global vascular guidelines on the management of chronic limb-threatening ischemia. Eur J Vasc Endovasc Surg. 2019;58(1S):S1–S109.e33. PMID: 31182334. PMCID: PMC8369495. https://doi.org/10.1016/j.ejvs.2019.05.006
3. Kazakov IuI, Lukin IB, Velikov PG, Strakhov MA. The choice of reconstruction technique of infrainguinal arterial segment in patients with chronic critical limb ischemia. Kardiologiya i Serdechno-Sosudistaya Khirurgiya. 2014;7(6):42–48. (In Russ.).
4. Ho VT, Gologorsky R, Kibrik P, et al. Open, percutaneous, and hybrid deep venous arterialization technique for no-option foot salvage. J Vasc Surg. 2020;71(6):2152–2160. PMID: 31901360. https://doi.org/10.1016/j.jvs.2019.10.085
5. Gavrilenko AV, Kravchenko AA, Kotov AÉ, Shatalova DV. Treatment of patients with critical lower limb ischaemia: endovascular methods or reconstructive operations. Angiol Sosud Khir. 2017;23(3):145–150. PMID: 28902825. (In Russ.).
6. Belov YuV, Vinokurov IA. The concept of surgical treatment of critical limb ischemia. Kardiologiya i Serdechno-Sosudistaya Khirurgiya. 2015;8(5):9–13. (In Russ.). https://doi.org/10.17116/kardio2015859-13
7. Gargiulo NJ 3rd, Veith FJ, O’Connor DJ, Lipsitz EC, Suggs WD, Scher LA. Experience with a modified composite sequential bypass technique for limb-threatening ischemia. Ann Vasc Surg. 2010;24(8):1000–1004. PMID: 20599342. https://doi.org/10.1016/j.avsg.2010.03.009
8. Pokrovsky AV, Yahontov DI. Value assessment in outflow tract reconstruction femoral-tibial. I.P. Pavlov Russian Medical Biological Herald. 2013;21(4):104–112. (In Russ.).
9. Krepkogorskiy NV, Ignatiev IM, Bredikhin RA, Illarionova IN. Tibioperoneal trunk repair in autovenous femoropopliteal bypass surgery. Kardiologiya i Serdechno-Sosudistaya Khirurgiya. 2019;12(5):467–471. (In Russ.). https://doi.org/10.17116/kardio201912051467
10. Bredikhin RA, Ignat’ev IM, Krepkogorskii NV, Bulatov DG. The first experience to prosthetics of tibioperoneal trunk by femoral-popliteal bypass. Kardiologiya i Serdechno-Sosudistaya Khirurgiya. 2017;10(2):58–61. (In Russ.). https://doi.org/10.17116/kardio201710258-61
11. Akchurin RS, Alekyan BG, Apkhanova TV, et al; Association of Cardiovascular Surgeons of Russia, Russian Society of Angiologists and Vascular Surgeons, Russian Society of Surgeons, Russian Society of Cardiology, Russian Association of Endocrinologists. National Guidelines on the Diagnosis and Treatment of Lower Extremity Artery Diseases. A.N. Bakulev National Medical Research Center of Cardiovascular Surgery; 2019. (In Russ.).
12. Hsu CC, Kwan GN, Singh D, Rophael JA, Anthony C, van Driel ML. Angioplasty versus stenting for infrapopliteal arterial lesions in chronic limb-threatening ischaemia. Cochrane Database Syst Rev. 2018;12(12):CD009195. PMID: 30536919. PMCID: PMC6517022. https://doi.org/10.1002/14651858.CD009195.pub2
13. de Boer SW, van Mierlo-van den Broek PAH, de Vries JPM, et al. Technical success and mid-term outcomes of endovascular revascularization of tibio-peroneal trunk lesions. J Clin Med. 2021;10(16):3610. PMID: 34441909. PMCID: PMC8396830. https://doi.org/10.3390/jcm10163610
14. Schreve MA, Vos CG, Vahl AC, et al. Venous arterialisation for salvage of critically ischaemic limbs: a systematic review and meta-analysis. Eur J Vasc Endovasc Surg. 2017;53(3):387–402. PMID: 28027892. https://doi.org/10.1016/j.ejvs.2016.11.007
15. Gavrilenko AV, Kotov AE, Loikov DA. Surgical treatment of critical lower limb ischemia in diabetic patients. Annals of Surgery. 2012;(2):10–15. (In Russ.).
16. Dardik H. Update on the role of the distal arteriovenous fistula as an adjunct for improving graft patency and limb salvage rates after crural revascularization. Ann Vasc Surg. 2015;29(5):1022–1028. PMID: 25770378. https://doi.org/10.1016/j.avsg.2015.02.003
17. An K, Mei J, Zhu J, Tang M. Correlates of haemodynamic flow characteristics of sequential saphenous vein grafts in coronary artery bypass grafting. Interact Cardiovasc Thorac Surg. 2019;28(5):683–688. PMID: 30561646. https://doi.org/10.1093/icvts/ivy335
18. Aherne T, Kheirelseid E, O’Neill D, et al. The use of arteriovenous fistulae as an adjunct to peripheral arterial bypass: a systematic review and meta-analysis. Eur J Vasc Endovasc Surg. 2016;51(5):707–717. PMID: 27067191. https://doi.org/10.1016/j.ejvs.2016.01.014
Review
For citations:
Krepkogorskiy N.V., Bredikhin R.A. Results of the tibioperoneal trunk repair in patients with advanced atherosclerosis. Innovative Medicine of Kuban. 2023;(2):13-20. (In Russ.) https://doi.org/10.35401/2541-9897-2023-26-2-13-20